alvespimycin hydrochloride

DRUG5 trials

Sponsors

National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI), Institute of Cancer Research, United Kingdom

Conditions

Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaB-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueIntraocular LymphomaLymphomaMale Breast CancerNodal Marginal Zone B-cell Lymphoma

Phase 1

17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma

CompletedNCT00088868

National Institutes of Health Clinical Center (CC)Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2004-06-30End: 2010-12-31Target: 40Updated: 2012-03-15

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

CompletedNCT00089271

National Cancer Institute (NCI)Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue +47

Start: 2004-07-31Updated: 2013-01-25

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

CompletedNCT00089362

National Cancer Institute (NCI)Male Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip +73

Start: 2004-07-31Updated: 2013-04-10

17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery

Institute of Cancer Research, United KingdomUnspecified Adult Solid Tumor, Protocol Specific

Start: 2005-10-31Target: 35Updated: 2013-08-02

Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia

TerminatedNCT01126502

National Cancer Institute (NCI)B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma +1

Start: 2010-05-31End: 2012-06-30Updated: 2015-11-04